Albumin fusion with granulocyte-macrophage colony-stimulating factor acts as an immunotherapy against chronic tuberculosis

A long duration of treatment and emerging drug resistance pose significant challenges for global tuberculosis (TB) eradication efforts. Therefore, there is an urgent need to develop novel strategies to shorten TB treatment regimens and to treat drug-resistant TB. Using an albumin-fusion strategy, we...

Descripción completa

Detalles Bibliográficos
Autores principales: Chuang, Yu-Min, He, Liangmei, Pinn, Michael L., Tsai, Ya-Chea, Cheng, Max A., Farmer, Emily, Karakousis, Petros C., Hung, Chien-Fu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8484439/
https://www.ncbi.nlm.nih.gov/pubmed/32382128
http://dx.doi.org/10.1038/s41423-020-0439-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8484439/
https://www.ncbi.nlm.nih.gov/pubmed/32382128
http://dx.doi.org/10.1038/s41423-020-0439-2

Ejemplares similares